Systemic inflammation and oxidative stress disrupt homocysteine metabolism and raise serum homocysteine.

The relationship between systemic inflammation, oxidative stress, and homocysteine (Hcy) metabolism represents a critical feedback loop in metabolic and vascular health. Research indicates that these states do not merely coexist but actively reinforce one another through biochemical disruptions.

Clinical evidence

There is strong clinical evidence linking systemic inflammation with elevated homocysteine levels. Studies across diverse populations—including those with metabolic syndrome, cardiovascular disease, and autoimmune conditions—consistently show that Hcy positively correlates with key inflammatory markers like high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). In multivariate models, homocysteine often remains an independent predictor of inflammatory status even after adjusting for variables such as age and BMI.

Mechanistic pathways

The disruption of homocysteine metabolism by inflammation and oxidative stress occurs through several distinct biochemical mechanisms:

• Enzymatic Inhibition: Oxidative stress directly interferes with B-vitamin–dependent enzymes. Reactive oxygen species (ROS) can oxidize the cobalamin(I) cofactor of methionine synthase (MTR), a B12-dependent enzyme. This "traps" the enzyme in an inactive state, preventing the remethylation of homocysteine back into methionine.
• Methyl Donor Depletion: Inflammatory stressors (such as lipopolysaccharides and cytokines) increase the metabolic demand for methyl donors like folate and methionine. This often leads to a depletion of S-adenosylmethionine (SAMe) and a decrease in the SAM/SAH ratio, impairing the body's overall methylation capacity.
• Pathway Shifting: Under oxidative pressure, the body may prioritize the transsulfuration pathway over remethylation. This shift is an adaptive response intended to produce glutathione, the body's master antioxidant, to combat ROS, but it contributes to the accumulation of homocysteine as an intermediate byproduct.
• Gene Expression: Oxidative stress can modulate the expression of MTHFR through endoplasmic reticulum (ER) stress pathways, further hindering efficient homocysteine processing.

Bottom line

Systemic inflammation and oxidative stress drive elevations in homocysteine by impairing B-vitamin–dependent enzymatic function and depleting methyl donor pools. This creates a pro-oxidant cycle where elevated homocysteine further exacerbates oxidative damage and inflammatory signaling.